BioLife to Showcase Oral Peptide Delivery Technology During London Life Sciences Week
3.11.2026 16:03:00 CET | Business Wire | Press Release
BioLife Products Limited today announced its participation in London Life Sciences Week, where it will highlight its patented oral peptide delivery technology and recent advances in its intellectual property portfolio.
BioLife will present at the LSX Investival Showcase on Monday, November 16, 2026, from 3:15 to 3:30 p.m. GMT, at Old Billingsgate, London. The presentation will be led by Former US Ambassador James P. Cain, Strategic Advisor to the Chairman & Founder, alongside Ludivine Delattre, Business and Corporate Relations, and will highlight the scientific journey behind the technology and its potential applications.
BioLife is focused on developing a novel approach to delivering peptide therapeutics orally. Built on over 35 years of pharmaceutical effervescence expertise and two decades of oral peptide research by founder and inventor Dr. Farid Bennis, the technology uses a dissolvable effervescent tablet to create a buffered solution that helps protect peptides during gastrointestinal transit and support systemic delivery.
"The rapid evolution of peptide medicines continues to create opportunities for innovation in drug delivery," said Dr. Farid Bennis, Founder of BioLife. "Our work reflects many years of research into the challenges of oral peptide delivery. London Life Sciences Week provides an important opportunity to share our progress and explore the potential of this approach with those advancing the next generation of peptide therapeutics."
Preclinical studies have demonstrated measurable systemic semaglutide exposure following oral administration, providing in vivo proof of concept. Combined with earlier human clinical research involving oral insulin formulations, these findings provide a scientific foundation for further investigation across additional peptide medicines, subject to further validation.
BioLife's technology is supported by granted patents in the United States and France, with additional international filings progressing. Its U.S. patent includes claims covering multiple GLP-1 receptor agonists, including semaglutide, liraglutide, dulaglutide, albiglutide, exenatide and lixisenatide, with protection extending into 2042.
About the Technology
BioLife's patented effervescent peptide delivery technology uses a dissolvable tablet to create a buffered solution designed to help protect peptide medicines during gastrointestinal transit and support systemic delivery. Preclinical studies have demonstrated measurable systemic semaglutide exposure following oral administration.
The development programme builds on nearly 20 years of research, including human clinical studies with oral insulin formulations and work with Charles River Laboratories, SGS, Eurofins/Amatsi and Cephac. The technology is in development and is not approved for the treatment of any disease.
About BioLife
BioLife develops oral delivery technologies for peptide medicines, combining expertise in pharmaceutical effervescence, formulation science and oral peptide research. The company's technology portfolio and related patent estate have been independently developed and are wholly owned.
Website: https://biolife.bio/
View source version on businesswire.com: https://www.businesswire.com/news/home/20261103294487/en/
Contacts
For Enquiries Contact
James P. Cain
U.S. Ambassador (Ret.)
Strategic Advisor to the Chairman & Founder
BioLife Products Limited
jpc@biolife.bio
Ludivine Delattre
Business and Corporate Relations
BioLife Products Limited
ld@biolife.bio
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026–2027 World Branding Awards Honours Global “ Brand of the Year ” Winners at Hampton Court Palace3.11.2026 21:00:00 CET | Press Release
The World Branding Awards returned to honour the brands that continue to set the benchmark for excellence. The 2026–2027 World Branding Awards Ceremony took place at the iconic Hampton Court Palace, marking the 21st edition of the awards. Set within the grandeur of a historic venue, the prestigious event brought together guests from across the globe for a memorable celebration. The evening was hosted by the acclaimed BBC presenter, Hannah Gray, and was further enriched by a keynote presentation from renowned speaker Adrian Webster. Earning a World Branding Awards remains a highly distinguished achievement. Winners are determined through a rigorous evaluation process encompassing brand valuation, consumer market research, and public online voting. This year, over 105,000 consumers took part in the voting process, and more than 2,000 brands from 62 countries were nominated. Of these, less than 10 brands from each country were declared the “Brand of the Year” across the Global, Regional,
Gencom Acquires Rosewood London, Expanding Its Footprint With Its First Luxury Hotel Acquisition in Europe3.11.2026 19:05:00 CET | Press Release
Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London, the landmark 308-key luxury hotel situated at 252 High Holborn in Central London. The acquisition strengthens Gencom’s global hospitality investment platform and expands its presence in Europe through its first luxury hotel asset in London. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103137897/en/ Gencom, a U.S.-based investment firm that owns and develops prized real estate around the world, announces the acquisition of Rosewood London in Central London London is one of the world’s most supply-constrained hospitality markets, supported by year-round demand from both leisure and business travelers. The acquisition of Rosewood London reflects Gencom’s conviction in the market and serves as a strategic entry point into Europe. The transaction further enhances the firm’s assemblage
SGCA Honours Communication Excellence Across Asia, Europe and the Arab World3.11.2026 16:52:00 CET | Press Release
His Highness Sheikh Dr Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, honoured winners of the 13th Sharjah Government Communication Award (SGCA), organised by the Sharjah Government Media Bureau (SGMB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103972039/en/ SGCA honours communication excellence across Asia, Europe and the Arab world (Photo: AETOSWire) Winners represented China, India, Thailand, Ukraine and the Arab world. Some 433 entries from 31 countries across four continents passed initial screening. The award covered 23 categories across five sectors, including six partner awards. His Excellency Tariq Saeed Allay, Director General of SGMB, highlighted the award’s growth under the vision of His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, noting that it had attracted more than 9,500 entries over five year
SharkNinja samlar sina stjärngrannar i sin första julkampanj3.11.2026 16:00:00 CET | Pressmeddelande
SharkNinja, ett globalt företag inom produktdesign och teknik, presenterar idag den sista filmen i sin första julkampanj någonsin. I huvudrollerna syns de globala varumärkesambassadörerna David Beckham, Tom Brady, Kevin Hart och Aryna Sabalenka. Kampanjen med titeln ”There’s No Home Like a SharkNinja Home” sätter ambassadörernas egen entusiasm för produkterna i fokus, när ett uppdrag som husvakt över jul spårar ur på ett charmigt sätt som bjuder in tittarna till festen. Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20261103956203/sv/ David Beckham, Tom Brady, Kevin Hart och Aryna Sabalenka firar sin gemensamma kärlek till Shark- och Ninja-produkter i SharkNinjas första julkampanj någonsin: ”There’s No Home Like a SharkNinja Home”. Julkampanjen är skapad av SharkNinjas in-house team Creative Labs och är producerad av Studio 99. Den bygger vidare på SharkNinjas serie Neighborsfrån 2025 med Beckham och Hart som grannar
Sceye and SoftBank Corp. Sign Agreement for Fleet of Stratospheric Platforms Targeting Nationwide Coverage in Japan3.11.2026 16:00:00 CET | Press Release
Sceye, a U.S. aerospace and material science company building High Altitude Platform Systems (HAPS) for stratospheric infrastructure, today announced a five-year Master Services Agreement (MSA) with SoftBank Corp. (TOKYO:9434, “SoftBank”) to manufacture, launch, and operate a fleet of Sceye’s HAPS over Japan with the aim of achieving nationwide coverage. This agreement advances the companies’ partnership from flight demonstrations toward full-scale stratospheric infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103391128/en/ Sceye and SoftBank Corp. Sign Agreement for Fleet of Stratospheric Platforms Targeting Nationwide Coverage in Japan Sceye’s HAPS will form a key pillar of SoftBank’s strategy for a Ubiquitous Network. The majority of Sceye’s initial fleet will provide mobile broadband throughout Japan, while a subset will also establish a Free Space Optical (FSO) network in the stratosphere. These deploym
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom